Next Article in Journal
A Novel, Validated Stability-Indicating UPLC Method for the Estimation of Lansoprazole and its Impurities in Bulk Drug and Pharmaceutical Dosage Forms
Previous Article in Journal
A Rapid, Validated RP-HPLC Method for the Simultaneous Determination of Cleaning Validation and Cross-Contamination of 12 Beta-Lactam Compounds
 
 
Scientia Pharmaceutica is published by MDPI from Volume 84 Issue 3 (2016). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Austrian Pharmaceutical Society (Österreichische Pharmazeutische Gesellschaft, ÖPhG).
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Development and Validation of a Stability-Indicating HPLC Method for the Simultaneous Determination of Sulfadiazine Sodium and Trimethoprim in Injectable Solution Formulation

by
Mashhour M. GHANEM
and
Saleh A. ABU-LAFI
*
*
Author to whom correspondence should be addressed.
Sci. Pharm. 2013, 81(1), 167-182; https://doi.org/10.3797/scipharm.1210-12
Accepted: 22 November 2012 / Published: 22 November 2012

Abstract

A direct, precise, and stability-indicating HPLC method that is based on reversed-phase liquid chromatography (RP-HPLC) coupled with a photodiode array detector (PDA) was developed, optimized, and validated for the simultaneous determination of sulfadiazine sodium (SDZS) and Trimethoprim (TMP) in Bactizine® forte injectable solution. The separation was achieved using a C18 column (250 mm×4.6 mm i.d., 5 μm particle size) at room temperature, and an isocratic mobile phase that consisted of a trinary solvent mixture of water–acetonitrile–triethylamine (838:160:2, v/v) at pH 5.5 ± 0.05. The mobile phase was delivered at 1.4 ml/min and the analytes were monitored at 254 nm. The effects of the operational chromatographic conditions on the peak’s USP tailing factor, column efficiency, and resolution were systematically optimized. Forced degradation experiments were carried out by exposing SDZS, TMP standards, and their formulation to thermal, photolytic, oxidative, and acid-base hydrolytic stress conditions. The method was successfully validated in accordance to International Conference on Harmonization (ICH) and United States Pharmacopoeia (USP34/NF29) guidelines and found to be suitable for the quantitative determination and stability of SDZS and TMP in Bactizine® forte injectable solution.
Keywords: Sulfadiazine sodium; Trimethoprim; Bactizine® forte injectable solution; Validation; Stability indicating method Sulfadiazine sodium; Trimethoprim; Bactizine® forte injectable solution; Validation; Stability indicating method

Share and Cite

MDPI and ACS Style

GHANEM, M.M.; ABU-LAFI, S.A. Development and Validation of a Stability-Indicating HPLC Method for the Simultaneous Determination of Sulfadiazine Sodium and Trimethoprim in Injectable Solution Formulation. Sci. Pharm. 2013, 81, 167-182. https://doi.org/10.3797/scipharm.1210-12

AMA Style

GHANEM MM, ABU-LAFI SA. Development and Validation of a Stability-Indicating HPLC Method for the Simultaneous Determination of Sulfadiazine Sodium and Trimethoprim in Injectable Solution Formulation. Scientia Pharmaceutica. 2013; 81(1):167-182. https://doi.org/10.3797/scipharm.1210-12

Chicago/Turabian Style

GHANEM, Mashhour M., and Saleh A. ABU-LAFI. 2013. "Development and Validation of a Stability-Indicating HPLC Method for the Simultaneous Determination of Sulfadiazine Sodium and Trimethoprim in Injectable Solution Formulation" Scientia Pharmaceutica 81, no. 1: 167-182. https://doi.org/10.3797/scipharm.1210-12

APA Style

GHANEM, M. M., & ABU-LAFI, S. A. (2013). Development and Validation of a Stability-Indicating HPLC Method for the Simultaneous Determination of Sulfadiazine Sodium and Trimethoprim in Injectable Solution Formulation. Scientia Pharmaceutica, 81(1), 167-182. https://doi.org/10.3797/scipharm.1210-12

Article Metrics

Back to TopTop